I Holland to host troubleshooting in tablet tooling seminar
Will include sharing information on industry trends and tooling expertise.
I Holland is marking this prestigious year by holding a variety of seminars in both the UK and around the world to provide the highest quality tooling and technical support service. The seminar will include sharing information on industry trends and tooling expertise to both prospective and existing customers.
The solutions-led seminar, held at I Holland’s UK manufacturing facility, has been created specifically for production managers, press operators and those directly involved in tooling maintenance.
Designed to identify and address common problems encountered during modern tablet production, the seminar will tackle elements of punch and die design, tooling specification and aftercare. Together, experts from within the pharmaceutical tooling industries will explore the problems that can arise in production, and troubleshoot how improved maintenance procedures can help businesses to decrease tablet press downtime, maximise quality and optimise production.
The two-day event will include a series of workshops on multi-tip tooling, tablet design and tool polishing in addition to an overview of problem solving with steels, coatings and other innovations.
“Increasingly, tabletting manufacturers are seeking new and innovative ways to troubleshoot common challenges relating to tablet tooling. Our seminars provide an inclusive and interactive environment for prospective and existing customers to discuss a variety of problems and how to overcome these effectively and efficiently,” says Alex Bunting, Marketing Manager, I Holland.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.